| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |